A surrogate biomarker of ICD is the release of HMGB1 from dying tumor cells, which is required for the processing and cross-presentation of antigens [27,28,29] and for the recruitment of T cells to the tumor microenvironment (TME) [33,34]. The gene discussed is HMGB1; the disease is neoplasm.